Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Release Date: September 12, 2025

Expiration Date: September 12, 2026

Activity Overview

Prostate cancer continues to pose substantial clinical challenges, with increasing incidence and mortality rates in the United States. While PSMA-directed radioligand therapy (RLT) and advanced imaging technologies have transformed the diagnosis and treatment of metastatic prostate cancer, knowledge gaps persist regarding optimal use, patient selection, sequencing, and integration into multidisciplinary care. Additionally, disparities in access and implementation across care settings underscore the urgent need for clinician education. To address these unmet needs, PER® has developed this online activity that features expert video interviews.

Target Audience

This activity is directed toward medical oncologists, urologists, radiation oncologists, nuclear medicine physicians, advanced practice providers, nurses, nurse navigators, and palliative care specialists.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

1. Identify barriers to receiving PSMA-directed radioligand therapy and strategies to expand access in the community setting
2. Devise strategies to overcome disparities in care and ensure equitable access to novel radioligand therapies in patients with mCRPC
3. Incorporate biomarker and imaging-based tools to guide multidisciplinary care and optimize outcomes with PSMA-targeted radioligand therapy